|
|
|
|
| LEADER |
03187nam a2200553 4500 |
| 001 |
ocn694142292 |
| 003 |
OCoLC |
| 005 |
20180501121938.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
100823s2010 ne a ob 001 0 eng d |
| 040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d N$T
|d EBLCP
|d YDXCP
|d OCLCQ
|d MHW
|d OCLCQ
|d OPELS
|d OCLCQ
|d UKDOC
|d OCLCQ
|d GrThAP
|
| 019 |
|
|
|a 669002715
|
| 020 |
|
|
|a 9780123808851
|q (electronic bk.)
|
| 020 |
|
|
|a 0123808855
|q (electronic bk.)
|
| 020 |
|
|
|a 9780123808844
|q (electronic bk.)
|
| 020 |
|
|
|a 0123808847
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)694142292
|z (OCoLC)669002715
|
| 050 |
|
4 |
|a RS403
|b .B75 2010eb
|
| 072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615/.1
|2 22
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Profiles of drug substances, excipients and related methodology.
|n Volume 35 /
|c edited by Harry G. Brittain.
|
| 250 |
|
|
|a 1st ed.
|
| 260 |
|
|
|a Amsterdam :
|b Elsevier,
|c 2010.
|
| 300 |
|
|
|a 1 online resource (ix, 396 pages) :
|b illustrations.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Profiles of drug substances, excipients, and related methodology,
|x 1871-5125 ;
|v v. 35
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Front Cover; Profiles of Drug Substances, Excipients, and Related Methodology; Copyright Page; Contents; Preface to Volume 35; Chapter 1: Atorvastatin Calcium; Chapter 2: Clopidogrel Bisulfate; Chapter 3: Donepezil; Chapter 4: Omeprazole; Chapter 5: Parbendazole; Chapter 6: Rocuronium Bromide; Chapter 7: Vigabatrin; Chapter 8: Zaleplon; Chapter 9: Cocrystal Systems of Pharmaceutical Interest; Cumulative Index.
|
| 520 |
|
|
|a Volumes in this widely revered series present comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. This organizational structure meets the needs of the pharmaceutical community and allows for the development of a timely vehicle for publishing review materials on this topic. The scope of the Profiles series encompasses review articles and database compilations that fall within one of the following six broad categories: Physical profiles of drug substances and.
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Drugs
|x Analysis.
|
| 650 |
|
0 |
|a Excipients
|x Analysis.
|
| 650 |
|
0 |
|a Pharmaceutical chemistry.
|
| 650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Brittain, H. G.
|
| 776 |
0 |
8 |
|i Print version:
|t Profiles of drug substances, excipients and related methodology. Vol. 35.
|d Oxford : Academic, 2010
|z 9780123808844
|w (OCoLC)495596388
|
| 830 |
|
0 |
|a Profiles of drug substances, excipients, and related methodology ;
|v v. 35.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/18715125/35
|z Full Text via HEAL-Link
|
